Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesotheliomaPaolo Andrea Zucali, Armando Santoro, Matteo Perrino et al.|Lung Cancer|2013Cited by 58
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)Yannis Metaxas, Roger von Moos, Christine Waibel et al.|Annals of Oncology|2020Cited by 32
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumorsMatteo Simonelli, Armando Santoro, Paolo Andrea Zucali et al.|European Journal of Cancer|2012Cited by 13
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell CarcinomaFabio De Vincenzo, Armando Santoro, Paolo Andrea Zucali et al.|Journal of Clinical Oncology|2011Cited by 9
Treatment of malignant pleural mesothelioma: current status and future directionsPaolo Andrea Zucali, Armando Santoro, Rita De Sanctis et al.|Clinical Investigation|2011Cited by 3